Digital Health Startups

Noninvasix develops a patented optoacoustic platform that non-invasively and continuously measures central venous oxygen saturation to help ICU clinicians diagnose and monitor tissue hypoxia in sepsis and septic shock patients in real time. The technology is aimed at critical care settings, with planned applications in fetal monitoring, neonatal care, traumatic brain injury, and blood loss.

5 investors

NorthSea Therapeutics is a clinical-stage biopharmaceutical company developing oral fatty acid-derived therapies for liver and metabolic diseases, including intestinal failure-associated liver disease (IFALD), severe hypertriglyceridemia, and MASH. Its programs target patient populations with limited existing treatment options.

5 investors

Nostos Genomics develops genetic testing interpretation tools to improve the accuracy, speed, and accessibility of variant analysis for patients with rare and genetic diseases. The company addresses the diagnostic bottleneck in genetic sequencing by providing better information interpretation for patients and healthcare systems.

5 investors

Nucleus provides genetic testing and analysis for couples planning pregnancy, screening for over 200 hereditary diseases, traits, and health conditions. For those undergoing IVF, the company offers embryo selection guidance to reduce disease risk and optimize traits including eye color, height, and intelligence.

5 investors

Numen develops at-home cancer diagnostics and health data collection infrastructure using machine learning models to enable earlier intervention and improve patient outcomes.

5 investors

Octave is a mental health practice platform that connects licensed therapists with patients seeking in-network mental health care. The company handles insurance credentialing, billing, scheduling, and client matching to support therapists and expand access to effective mental health treatment.

5 investors

Oculogica develops FDA-cleared concussion assessment devices that use proprietary eye-tracking technology to measure abnormal eye movements caused by traumatic brain injury. Its tools serve clinicians and athletic trainers across settings including sports sidelines, pediatric and urgent care clinics, accident/personal injury clinics, and military care.

5 investors

Oliva is a therapy and professional coaching platform for companies, offering individual and group coaching, full-spectrum therapy, and manager support through a flexible plan. It serves employers and HR teams looking to support employee mental health and build high-performing team dynamics, aggregating anonymised session data into insights on common challenges and skill gaps.

5 investors

OMNY Health operates a platform that connects patients, providers, and life sciences companies through data and insights to improve healthcare delivery and clinical outcomes.

5 investors

Qualifacts provides AI-powered electronic health record (EHR) software, data tools, and interoperability services for behavioral health agencies, both non-profit and for-profit. Its offerings support clinical documentation, workflow automation, data insights, and secure data exchange for clinicians and administrators across the United States.

5 investors

OncoLens provides a platform that connects cancer care teams and enables multidisciplinary cancer management, helping cancer centers coordinate care, manage tumor boards, and access clinical trials and biomarker testing.

5 investors

Oncoustics develops ultrasound-based artificial intelligence and machine learning solutions for cancer detection and liver disease characterization, serving clinical researchers and healthcare providers. The company operates research collaborations with Stanford University, University of Toronto, and international health institutes across Toronto, Cairo, and Palo Alto.

5 investors

OncoveryCare develops survivorship care solutions for cancer survivors, addressing the medical and quality-of-life needs of people living after cancer treatment.

5 investors

OneStep uses smartphone-based AI to perform clinical-grade gait analysis and motion detection for healthcare providers. The platform helps identify fall risk, track recovery, and monitor mobility-related conditions across chronic pain, neurological, cardiac, and post-surgical care.

5 investors

Ophelia provides medication-assisted treatment for opioid addiction through a telemedicine platform, allowing patients to receive care without attending residential rehab. The service is designed for individuals struggling with opioid addiction who prefer privacy-respecting, home-based treatment options.

5 investors

OPTiM/OPTFIT is a Japanese company that develops AI-based products including "KaigoDX", a system offering bed-exit and fall detection for elderly care settings, and products for the fitness/sports sector. It serves care facilities and fitness operators in Japan.

5 investors

Oto is a tinnitus management program combining professional audiologist care with a mobile app delivering cognitive behavioral therapy exercises, soundscapes, and mindfulness techniques. The service serves adults living with tinnitus seeking clinical support and daily digital tools.

5 investors

Ours Privacy is a HIPAA-compliant customer data platform and privacy tool that lets healthcare marketers run ads and analytics through tools like GA4, Google Ads, and Meta while preventing sensitive patient data from reaching non-compliant destinations. It offers event redaction, identity stitching, multi-touch attribution, and 50+ integrations for healthcare companies ranging from startups to health systems.

5 investors

Pager Health provides a white-label care navigation platform that combines AI with clinicians to help members find, access, and stay engaged with healthcare. It is offered to health plans as SaaS or a fully-staffed solution, covering care navigation, engagement, virtual health, and wellbeing.

5 investors

Panakeia develops software for biomarker profiling aimed at making precision diagnostics faster and instrument-free, to inform cancer diagnosis, treatment, and drug development. Its solutions target clinicians and researchers working in precision medicine and oncology.

5 investors

Parallel provides evidence-based services and assessment tools for schools and education providers to support students with learning differences. The platform connects educators and specialists to help diagnose and address conditions like dyslexia and ADHD.

5 investors

Paterna Biosciences is developing a first-in-class biologic for reproductive biology using in vitro spermatogenesis technology. The company is advancing cell and gene therapy programs toward FDA approval.

5 investors

Pathos applies AI, biological modeling, and a large collection of multimodal oncology patient data to develop cancer drugs and accelerate clinical development. It operates the PathOS platform with engines for asset selection, clinical trial execution, and an oncology foundation model.

5 investors

A precision oncology company providing genomic testing and resources to support cancer care decisions, operating under Labcorp Oncology.

5 investors